CTRI/2022/06/043126RecruitingPhase 2
A Multi-centre Open label Phase II clinical trial to compare the effectiveness and safety of local anaesthesia by polyherbal local anesthetic injection and lignocaine hydrochloride in minor surgical procedures
Pankajakasthuri Herbals India Pvt Ltd0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Subjects indicated for minor surgical procedures under Local anaesthesia; Willing to enroll in the study by signing the informed consent.
Exclusion Criteria
- •1. Hypersensitivity to any one of the ingredients in the polyherbal local anaesthetic injection, lignocaine hydrochloride or to any local anaesthetic agent of amide type.
- •2. Uncontrolled hypertension/congenital heart problems.
- •3. Any chronic illness with life-threatening comorbidities.
- •4. Impaired cardiovascular and respiratory function.
- •5. Patients with medicament-induced altered pain perception.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADE (Bortezomib) in Patients with Malignant Pleural Mesothelioma - Phase II Velcade Mesothelioma trialMalignant Pleural Mesothelioma (in first line, and second line treatment settings)EUCTR2005-004420-39-IEAll-Ireland Co-operative Oncology Research Group (ICORG)111
Completed
Phase 2
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADETM (Bortezomib) in Patients with Malignant Pleural Mesotheliomapleural cancermesothelioma10027412NL-OMON30139All Ireland Cooperative Oncology Research Group8
Active, not recruiting
Phase 1
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADE (Bortezomib) in Patients with Malignant Pleural Mesothelioma - Phase II Velcade Mesothelioma trialEUCTR2005-004420-39-GBAll-Ireland Co-operative Oncology Research Group (ICORG)111
Active, not recruiting
Not Applicable
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADE (Bortezomib) in Patients with Malignant Pleural Mesothelioma - Phase II Velcade Mesothelioma trialEUCTR2005-004420-39-BEniversity Hospital Gent136
Active, not recruiting
Not Applicable
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADE (Bortezomib) in Patients with Malignant Pleural Mesothelioma - Phase II Velcade Mesothelioma trialMalignant Pleural Mesothelioma (in first line, and second line treatment settings)EUCTR2005-004420-39-NLAll-Ireland Co-operative Oncology Research Group (ICORG)111